Ivan Bergstein
2012
In 2012, Ivan Bergstein earned a total compensation of $746.5K as President and Chief Executive Officer at Stemline Therapeutics, a 42% increase compared to previous year.
Compensation breakdown
| Option Awards | $396,470 |
|---|---|
| Salary | $350,000 |
| Total | $746,470 |
Bergstein received $396.5K in option awards, accounting for 53% of the total pay in 2012.
Bergstein also received $350K in salary.
Rankings
In 2012, Ivan Bergstein's compensation ranked 7,304th out of 11,487 executives tracked by ExecPay. In other words, Bergstein earned more than 36.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,304 out of 11,487 | 36th |
Division Manufacturing | 2,619 out of 4,253 | 38th |
Major group Chemicals And Allied Products | 672 out of 1,198 | 44th |
Industry group Drugs | 466 out of 920 | 49th |
Industry Pharmaceutical Preparations | 367 out of 700 | 48th |
Source: SEC filing on April 30, 2015.
Bergstein's colleagues
We found four more compensation records of executives who worked with Ivan Bergstein at Stemline Therapeutics in 2012.